Legal & General Group Plc - RAPTOR PHARMACEUTICAL CORP ownership

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$96,000
+21.5%
10,699
-28.5%
0.00%
Q2 2016$79,000
+17.9%
14,9560.0%0.00%
Q1 2016$67,000
+26.4%
14,956
+46.8%
0.00%
Q4 2015$53,000
-11.7%
10,1850.0%0.00%
Q3 2015$60,000
-62.5%
10,1850.0%0.00%
Q2 2015$160,000
+37.9%
10,1850.0%0.00%
Q1 2015$116,000
+6.4%
10,1850.0%0.00%
Q4 2014$109,000
+6.9%
10,1850.0%0.00%
Q3 2014$102,00010,1850.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders